{"id":2862,"date":"2024-10-11T06:25:43","date_gmt":"2024-10-11T06:25:43","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/impurities-in-new-veterinary-medicinal-products-revision\/"},"modified":"2024-10-23T13:15:38","modified_gmt":"2024-10-23T13:15:38","slug":"impurities-in-new-veterinary-medicinal-products-revision","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/fr\/guidline\/impurities-in-new-veterinary-medicinal-products-revision\/","title":{"rendered":"Impuret\u00e9s dans les nouveaux m\u00e9dicaments v\u00e9t\u00e9rinaires (R\u00e9vision)"},"content":{"rendered":"<p>VICH GL11(R) (Qualit\u00e9 &#8211; Impuret\u00e9s des substances) &#8211; Mise en \u0153uvre en janvier 2008<\/p>\n","protected":false},"menu_order":150,"template":"","meta":[],"guideline_category":[244],"class_list":["post-2862","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-quality-impurities-fr"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline\/2862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/media?parent=2862"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline_category?post=2862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}